Boehringer Ingelheim Pharmaceuticals, Inc.
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and consequences of Ischemic stroke
Boehringer Ingelheim Pharmaceuticals, Inc. - Research Presentations 2012 AAPS Annual Meeting and Exposition
Spatially resolved characterization of capping using nondestructive ultrasonics and finite element modeling
No infographics yet
No likes yet
Personal Information
Organization / Workplace
Boehringer Ingelheim Pharmaceuticals, Inc.Location
Ridgefield, Connecticut United StatesIndustry
Medical / Health Care / Pharmaceuticals
Website
us.boehringer-ingelheim.com/About
The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us build on our strengths and make the most of our distinctive character for 125 years. Value through Innovation is what drives us to continuously search for new and innovative ways to improve the lives that we touch - whether that be lives of patients and their families, our employees or our community.